Table 2 Comparison of immunohistochemical indexes of 57 renal eAML patients
Variable | Entire group (n = 57) | No recurrence/metastasis (n = 40) | Recurrence/metastasis (n = 17) | P value |
|---|---|---|---|---|
HMB45 (−/ +) | 7/50 | 4/36 | 3/14 | 0.421 |
Melan-A (−/ +) | 11/46 | 7/33 | 4/13 | 0.598 |
SMA (-/ +) | 14/43 | 5/35 | 9/8 | 0.001 |
PNL-2 (−/ +) | 21/36 | 13/27 | 8/9 | 0.297 |
Desmin (−/ +) | 43/14 | 31/9 | 12/5 | 0.579 |
CD34 (−/ +) | 44/13 | 33/7 | 11/6 | 0.143 |
AE1/AE3 (−/ +) | 53/4 | 36/4 | 17/0 | 0.176 |
CK7 (−/ +) | 51/6 | 35/5 | 16/1 | 0.456 |
Vimentin (−/ +) | 17/40 | 13/27 | 4/13 | 0.498 |
TFE3-OPT (−/ +) | 42/15 | 30/10 | 12/5 | 0.729 |
PAX8 (−/ +) | 49/8 | 35/5 | 14/3 | 0.609 |
CD10 (−/ +) | 49/8 | 36/4 | 13/4 | 0.179 |
S-100 (−/ +) | 30/27 | 19/19 | 11/8 | 0.574 |
Ki-67 (n, %) | < 0.001 | |||
< 10% | 40 (70.2) | 34 (89.5) | 6 (31.6) | |
≥ 10 | 17 (29.8) | 4 (10.5) | 13 (68.4) |